Global Diabetic Retinopathy Treatment Market By Treatment Type (Laser Surgery, Vitrectomy, Intraocular Steroid Injection, Anti-Vascular Endothelial Growth Factor Drug), Type (Non-Proliferative, Proliferative), Device Type (Focal Laser Treatment, Vitrectomy Devices, Scatter Laser Treatment), Drug Type (Aflibercept, Bevacizumab, Fluocinolone, Ranibizumab, Triamcinolone Acetonide Injection), End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Diabetic Retinopathy Treatment Market
Diabetic retinopathy treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 11.44 billion by 2027 growing with the CAGR of 6.35% in the above-mentioned forecast period. The rising cases of diabetes among the world population as diabetes causes damage to the eyes will help in driving the growth of the diabetic retinopathy treatment market.
Increased income and avoidance of blindness in patients, favourable reimbursement policies will likely to accelerate the growth of the diabetic retinopathy treatment market in the forecast period of 2020-2027. On the other hand, rising global geriatric population is expected to heighten the susceptibility towards chronic disorders such as cardiovascular disorders, diabetes, and sleep disorders will further boost various opportunities that will lead to the growth of the diabetic retinopathy treatment market in the above mentioned forecast period.
Lack of insurance and information regarding the disease and lack of skilled and experienced ophthalmologists will likely to hamper the growth of the diabetic retinopathy treatment market in the above mentioned forecast period.
This diabetic retinopathy treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on diabetic retinopathy treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Diabetic Retinopathy Treatment Market Scope and Market Size
Diabetic retinopathy treatment market is segmented on the basis of treatment type, type, device type, drug type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on treatment type, the diabetic retinopathy treatment market is segmented into laser surgery, vitrectomy, intraocular steroid injection and anti-vascular endothelial growth factor drug.
- Based on type, the diabetic retinopathy treatment market is segmented into non-proliferative, and proliferative
- Based on device type, the diabetic retinopathy treatment market is segmented into focal laser treatment, vitrectomy devices and scatter laser treatment
- Based on drug type, the diabetic retinopathy treatment market is segmented into aflibercept, bevacizumab, fluocinolone, ranibizumab and triamcinolone acetonide injection
- Based on end user, the diabetic retinopathy treatment market is segmented into hospitals, ophthalmic clinics and ambulatory surgical centers
Diabetic Retinopathy Treatment Market Country Level Analysis
Diabetic retinopathy treatment market is analysed and market size insights and trends are provided by country, treatment type, type, device type, drug type and end user as referenced above.
The countries covered in the diabetic retinopathy treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the diabetic retinopathy treatment market due to high market penetration of Avastin, Eylea and Lucentis which are anti-VEGF drugs, largest share owing to the supportive reimbursement policies and increasing prevalence of diabetes, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to the high healthcare expenditure and rising disposable income. Moreover, growing usage of Lucentis is expected to drive market growth in this region.
The country section of the diabetic retinopathy treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Diabetic retinopathy treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for diabetic retinopathy treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the diabetic retinopathy treatment market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Diabetic Retinopathy Treatment Market Share Analysis
Diabetic retinopathy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to diabetic retinopathy treatment market.
The major players covered in the diabetic retinopathy treatment market report are Bayer AG, IDx Technologies Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Oxurion NV., Regeneron Pharmaceuticals Inc., Sirnaomics, Inc., Allergan, Abbott., Bausch Health Companies Inc., Kowa Company, Ltd., Alimera Sciences., Glycadia, Inc., Ampio Pharmaceuticals Inc., Sirnaomics, Inc., IRIDEX Corporation, Lumenis., Valon Lasers among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global Diabetic Retinopathy Treatment Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.